14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 61 days ( 0 % )
Last Price $0.0160 0 %
High/ Low $0.0160 - $0.0160 0%
Chg 7 Days N/A $0.0160 $0.0160
Chg 30 Days N/A $0.0160 $0.0160
Chg 12 mos -96.76 % $0.494 $0.0160
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos -73.44 % Width: 173.51 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos N/A - $0.0539 -100.00 % - 237.09 %
Short MA avg 3 mos Sell Oct 05, 2023 - 59 days
Long MA avg 3 mos Sell Nov 14, 2023 - 31 days
Short/Long MA avg 3 mos Sell Nov 14, 2023 - 31 days
Short MA avg 12 mos Sell Oct 25, 2023 - 45 days
Long MA avg 12 mos Sell Jul 21, 2023 - 112 days
Short/Long MA avg 12 mos Sell Aug 03, 2023 - 103 days
Pivot Short Sell Dec 27, 2023 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Infinity Pharmaceuticals

Infinity Pharmaceuticals Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the tre... INFI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT